The importance of broadly measuring Fc mediated effector function early in the antibody development process
May 12, 2025
Authors: Crescioli, S, Jatiani, S, & Moise, L, (2025). mAbs, 17(1).
Journal: mAbs
Journal Abstract/ Summary: Journal Abstract: Antibody therapeutics are rapidly evolving, with new formats and engineered designs expanding their potential across a range of diseases. A comprehensive evaluation of Fc-mediated effector functions early in development is critical to guide safe, effective therapeutic design.
Authors: Atyeo et al. Immunity (2020)
Authors: Kaplonek P, et al. Sci Transl Med. 2022 May 18;14(645):eabm2311.
Authors: Hawman, David W. et al. eBioMedicine, Volume 115, 105698